A clinical trial of EXP 338 in the treatment of a neurotic population.
D002707:Chlordiazepoxide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D009497:Neurotic Disorders / Q000188:drug therapy*; D010919:Placebos; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D007093:Imidazoles; D010919:Placebos; D014149:Tranquilizing Agents; D002707:Chlordiazepoxide